Search results
Results from the WOW.Com Content Network
Deracoxib is a coxib class nonsteroidal anti-inflammatory drug (NSAID). [3] Like other NSAIDs, its effects are caused by inhibition of cyclooxygenase (COX) enzymes. [7] At the doses used to treat dogs, deracoxib causes greater inhibition of COX-2 than of COX-1, [3] but at doses twice those recommended for use in dogs, deracoxib significantly inhibits COX-1 as well.
Maropitant is safer than other antiemetics used in veterinary medicine, in part because of its high specificity for its target and thus not binding to other receptors in the central nervous system. [6] Side effects in dogs and cats include hypersalivation, diarrhea, loss of appetite, and vomiting.
Disadvantages of mitotane as a treatment include the side effects and the requirement for blood test monitoring. Issues can arise when too much of the adrenal cortex becomes eroded. Approximately 30% of dogs will experience a reaction in response to treatment with mitotane; prednisone may be used as an antidote. In the event of a reaction ...
The interleukin-3 receptor is a molecule found on cells which helps transmit the signal of interleukin-3, a soluble cytokine important in the immune system. The gene coding for the receptor is located in the pseudoautosomal region of the X and Y chromosomes .
Cyproheptadine is a very potent antihistamine or inverse agonist of the H 1 receptor. At higher concentrations, it also has anticholinergic, antiserotonergic, and antidopaminergic activities. Of the serotonin receptors, it is an especially potent antagonist of the 5-HT 2 receptors.
Side effects include urinary retention, dry mouth, blurred vision; Glycopyrrolate: Quaternary ammonium compound; Does not cross blood-brain barrier; Hyperhidrosis. Reduce rate of sweating by blocking parasympathetic receptors in the central nervous system, smooth muscle, and sweat glands [8] First drug approved by FDA in 2018 for hyperhidrosis [11]
The prostaglandin D 2 (PGD 2) receptor is activated when it comes into contact with PGD 2 which is released in the presence of allergens. A research study has been conducted to find an antagonist to the PGD 2 receptor, DP1, to possibly treat congestion. ONO-4053 is an antagonist that was used on dogs to help with allergic rhinitis caused by PGD 2.
Yohimbine is an α 2-adrenergic receptor antagonist, and has been used in a variety of research projects. It is a veterinary drug used to reverse sedation in dogs and deer. While yohimbine behaves as an aphrodisiac in some mammals, it does not do so in humans.